AbCellera Biologics Inc vs Indonesia Energy Corporation Limited — how do they compare? AbCellera Biologics Inc trades at $9.07 (market cap $2.99B), while Indonesia Energy Corporation Limited trades at $2.91 (market cap $45.55M). The key difference: AbCellera Biologics Inc is far larger — about 65.6× Indonesia Energy Corporation Limited's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Indonesia Energy Corporation Limited nearer its low. Which is the better fit depends on your goals.
| ABCL | INDO | |
|---|---|---|
Market Cap | $2.99B | $45.55M |
Sector | Health | Energy |
52-Week High | $9.76 | $6.74 |
52-Week Low | $2.78 | $2.49 |
Enterprise Value | $2.58B | $40.92M |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →